Nagia Afifi
Professor of Pharmaceutics and Industrial Pharmacy
(email)
Publications
Export 7 results:
RTF
Tagged
XML
BibTex
Sort by:
Author
Title
Type
[
Year
]
2012
Tammam, S., S. Mathur, and N. Afifi,
"
Preparation and Biopharmaceutical Evaluation of Tacrolimus Loaded Biodegradable Nanopaticles for Liver Targeting
",
J. Biomed. Nanotech.
, vol. 8, issue 3, pp. 439-449, 2012.
2011
Afifi, N. N., O. A. Heikal, R. S. Hanafi, and S. N. Tammam,
"
Application of Biodegradable Nanoparticles in Liver Targeting of Tacrolimus
",
Biology, Nanotechnology, Toxicology, and Applications: AIP Conference Proc. 1326, 120-127
, vol. AIP conference Proceedings, issue 1326, pp. 120-127, 2011.
2008
Zaki, C. M., N. N. Afifi, and H. A. Moneim,
"
Cefepime Stability in IV Solutions and Admixtures
",
Canadian Journal of Hospital Pharmacy: 61(5), 356 (2008).
, vol. 61, issue 5, pp. 356, 2008.
Zaki, C. M., N. N. Afifi, M. M. M. Hussein, and H. A. Moneim,
"
The Physical, Chemical and Therapeutic Incompatibilities of Admixtures of IV Cephradine with Selected Drugs
",
Hospital Pharmacist
, vol. 15, pp. 339-345, 2008.
2007
Zaki, C. M., N. N. Afif, M. M. Hussein, and E. M. S. Samaligy,
"
Cefepime Compatibilility
",
Canadian Journal of Hospital Pharmacy:60,338-339
, vol. 60, pp. 338-339, 2007.
2006
SAMALIGI, E. L. M. S., N. N. AFFIFI, and E. A. MAHMOUD,
"
21- INCREASING BIOAVAILABILITY OF SILYMARIN USING BUCCAL LIPOSOMAL DELIVERY SYSTEM: PREPARATION INVESTIGATION AND EXPERIMENTAL DESIGN
",
INTERNATIONAL JOURNAL OF PHARMACEUTICS: 308, 140-148 (2006)
, vol. 308, pp. 140-148, 2006.
SAMALIGI, E. L. M. S., N. N. AFFIFI, and E. A. MAHMOUD,
"
22- EVALUATION OF HYBRID LIPOSOMES- ENCAPSULATED SILYMARIN REGARDING PHYSICAL STABILITY AND IN-VIVO PERFORMANCE
",
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, vol. 319, pp. 121-129, 2006.
Publications
Bio
Classes
Calendar
Tags
bioavailability
(1)
biodegradable
(1)
biodegradable nanoparticles
(1)
buccal delivery
(1)
Cefepime
(2)
Cephradine
(1)
hybrid liposomes
(1)
in-vivo performance
(1)
incompatibilities
(1)
incompatibility
(1)
intravenous-admixture
(1)
IV admixture
(1)
IV admixtures
(1)
IV solution
(1)
liposomal carrier
(1)
liver targeting
(2)
nanoparticles
(1)
PLAG
(1)
PLG
(1)
Silymarin
(2)
stability
(4)
Tacrolimus
(2)
Recent Publications
Preparation and Biopharmaceutical Evaluation of Tacrolimus Loaded Biodegradable Nanopaticles for Liver Targeting
Application of Biodegradable Nanoparticles in Liver Targeting of Tacrolimus
Cefepime Stability in IV Solutions and Admixtures
The Physical, Chemical and Therapeutic Incompatibilities of Admixtures of IV Cephradine with Selected Drugs
Cefepime Compatibilility
more
Tourism